Abbracchio, M. P. and Burnstock, G., Purinoceptors: are there families of P2X and P2Y purinoceptors?Pharmacol. Ther., 64, 445–475 (1994).
Adrian, K., Bernhard, M. K., Breitinger, H. G., and Ogilvie, A., Expression of purinergic receptors ionotropic P2X1-7 and metabotropic P2Y1-11 during myeloid differentiation of HL60 cells.Biochim. Biophys. Acta., 1492, 127–138 (2000).
Barnard, E. A., Burnstock, G., and Webb, T. E., G protein-coupled receptors for ATP and other nucleotides: a new receptor family.Trends Pharmacol. Sci., 15, 67–70 (1994).
Bean, B. P., Pharmacology and electrophysiology of ATP-activated ion channels.Trends Pharmacol. Sci., 13, 87–90 (1992).
Berchtold, S., Ogilvie, A. L., Bogdan, C., Muhl-Zurbes, P., Ogilvie, A., Schuler, G., and Steinkasserer, A., Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases.FEBS Letter, 458, 424–428 (1999).
Burnstock, G., Do some nerve cells release more than one transmitter?Neuro., 1, 239–248 (1976).
Burnstock G. and Kennedy C., Is there a basis for distinguishing two types of P2-purinoreceptor?Gen. Pharmacol., 16, 433–440 (1985).
Burnstock G., The past, present and future of purine nucleotides as signalling molecules.Neuropharmacology, 36, 1127–1139 (1997).
Chiba, S., Takaku, F., Tange, T., Shibuya, K., Misawa, C., Sasaki, K., Miyagawa, K., Yazaki, Y., and Hirai, H., Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36P: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.Blood, 78, 2261–2268 (1991).
Chow, S. C., Kass, G. E., and Orrenius, S., Purines and their roles in apoptosis.Neuropharmacology, 36, 1149–1156 (1997).
Dawicki, D. D., Rounds, S., Chatterjee, D., and Wyche, J. H., Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cell.Am. J. Physiol., 273, 485–494 (1997).
De Mey, J. G. and Vanhoutte, P. M., Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries.J. Physiol., 316, 347–355 (1981).
Di Virgilio, F., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., and Baricordi, O. R., Nucleotide receptors: an emerging family of regulatory molecules in blood cells.Blood, 97, 587–600 (2001).
Ferrari, D., La Sala, A., Chiozzi, P., Morelli, A., Falzoni, S., Girolomoni, G., Idzko, M., Dichmann, S., Norgauer, J., and Di Virgilio, F., The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release.FASEB J., 14, 2466–2476 (2000).
Fang, W. G., Pirnia, F., Bang, Y. J., Myers, C. E., and Trepel, J. B., P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells.J. Clin. Invest., 89, 191–196 (1992).
Furchgott, R. F. and Zawadzki, J. V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.Nature, 288, 373–376 (1980).
Gallagher, R., Collins, S., Trujillo, J., McCredie, K., Ahearn, M., Tsai, S., Metzgar, R., Aulakh, G., Ting, R., Ruscetti, F., and Gallo, R., Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.Blood, 54, 713–733 (1979).
Garcia-Calvo, M., Peterson, E. P., Leiting, B., Ruel, R., Nicholson, D. W., and Thornberry, N. A., Inhibition of caspases by peptide-based and macromolecular inhibitors.J. Biol. Chem., 273, 32608–32613 (1998).
Greenberg, S., Di Virgilio, F., Steinberg, T. H., and Silverstein, S. C., Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms.J. Biol Chem., 263, 10337–10343 (1988).
Harden, T. K., Boyer, J. L., and Nicholas, R. A., P2-purinergic receptors: subtype-associated signaling responses and structure.Annu. Rev. Pharmacol. Toxicol., 35, 541–579 (1995).
Holton, P., The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves.J. Physiol., 145, 494–504 (1959).
Humphreys, B. D., Rice, J., Kertesy, S. B., and Dubyak, G. R., Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor.J. Biol. Chem., 275, 26792–26798 (2000).
Jin, J., Dasari, V. R., Sistare, F. D., and Kunapuli, S. P., Distribution of P2Y receptor subtypes on haematopoietic cells.Br. J. Pharmacol., 123, 789–794 (1998).
Kizaki, H., Suzuki, K., Tadakuma, T., and Ishimura, Y., Adenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death throgh internucleosomal DNA cleavage.J. Biol. Chem., 265, 5280–5284 (1990).
Kunapuli, S. P. and Daniel, J. L., P2 receptor subtypes in the cardiovascular system.Biochem. J., 336, 513–523 (1998).
Lee, H., Suh, B. C., and Kim, K. T., Feedback regulation of ATP-induced Ca2+ signaling in HL-60 cells is mediated by protein kinase A- and C-mediated changes in capacitative Ca2+ entry.J. Biol. Chem., 272, 21831–21838 (1997).
Mutini, C., Falzoni, S., Ferrari, D., Chiozzi, P., Morelli, A., Baricordi, O. R., Ginetta, C., Ricciardi Castagnoli, P., and Di Virgilio, F., Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation.J. Immunol., 163, 1958–1965 (1999).
Perregaux, D. and Gabel, C. A., Interleukin-1å maturation and release in response to ATP and nigericin: evidence that potassium depletion by these agents is a necessary and common feature of their activity.J. Biol. Chem., 269, 15195–15203 (1994).
Ralevic, V. and Burnstock, G., Receptors for purines and pyrimidines.Pharmacol. Rev., 50, 413–492 (1998).
Rapaport, E., Experimental cancer therapy in mice by adenine nucleotides.Eur. J. Cancer Clin. Oncol., 24, 1491–1497 (1988).
Steinberg, T. H., Newman, A. S., Swanson, J. A., and Silverstein, S. C., ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes.J. Biol. Chem., 262, 8884–8888 (1987).
Tanaka, Y., Yoshihara, K., Tsuyuki, M., and Kamiya, T., Apoptosis induced by adenosine in human leukemia HL-60 cells.Exp. Cell Res., 213, 242–252 (1994).
Von kugelgen, I., and Wetter, A., Molecular Pharmacology of P2Y receptors.Naunyn Schmiedeberg's Arch. Pharmacol., 362, 310–323 (2000).
Wakade, T. D., Palmer, K. C., Mccauley, R., Przywara, D. A., and Wakade, A. R., Adenosine-induced apoptosis in chick embryonic sympathetic neurons-a new physiological-role for adenosine.J. Physiol., 488, 123–138 (1995).
Weisman, G. A., Lustig, K. D., Lane, E., Huang, N. N., Belzer, I., and Friedberg, I., Growth inhibition of transformed mouse fibroblasts by adenine nucleotides occurs via generation of extracellular adenosine.J. Biol. Chem., 263, 12367–12372 (1988).
Wilkinson, G. F., Purkiss, J. R., and Boarder, M. R., The regulation of aortic endothelial cells by purines and pyrimidines involves co-existing P2y-purinoceptors and nucleotide receptors linked to phospholipase C.Br. J. Pharmacol., 108, 689–693 (1993).